<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03558568</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT03558568</nct_id>
  </id_info>
  <brief_title>The Effect of Deep Brain Stimulation on Facial Expressions.</brief_title>
  <acronym>STN-DBS</acronym>
  <official_title>The Effect of Subthalamic Nucleus Deep Brain Stimulation on Facial Expressions in Parkinson's Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mustafa Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mustafa Kemal University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Whether Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS), a treatment commonly used to&#xD;
      ameliorate the motor symptoms of Parkinson's disease (PD), affects on facial expressions is&#xD;
      unclear. The purpose of this study was to investigate the potential effects of DBS and&#xD;
      different frequencies on facial expressions of PD patients by volunteers via a web site:&#xD;
      http://www.supporttoscience.com&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parkinson's disease (PD) is the second most frequent progressive neuro-degenerative disease&#xD;
      with a worldwide prevalence of 4-6 million and the mask face is an important and also&#xD;
      troublesome sign of PD. Deep Brain Stimulation (DBS) surgery can be a viable option which has&#xD;
      recently emerged and been accepted as a useful surgical method for PD. Standard DBS targets&#xD;
      include Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi). Although the STN-DBS&#xD;
      application is known to have favorable effects on motor and non-motor symptoms of PD, there&#xD;
      is a lack information about the effect on facial expressions of PD patients. Our aim is to&#xD;
      analyze the effect of the STN-DBS stimulation and different frequencies on the facial&#xD;
      expressions of PD patients.&#xD;
&#xD;
      The study initially recruited 18 patients with idiopathic PD who underwent DBS surgery for&#xD;
      movement disorders caused by PD at Mustafa Kemal University Medical Faculty Neurosurgery&#xD;
      Department.&#xD;
&#xD;
      Inclusion criteria:&#xD;
&#xD;
        -  Idiopathic PD responsive to L-Dopa treatment,&#xD;
&#xD;
        -  Between 40-75 years of age,&#xD;
&#xD;
        -  Having received bilateral STN DBS surgery at least six months prior to the investigation&#xD;
           to ensure stable stimulation parameters,&#xD;
&#xD;
        -  Mentally normal patients that could understand and respond to a directives. The&#xD;
           evaluation will be made by the face photos of the patients. The face photos for the&#xD;
           expressions including [normal], [sad], [happy], and [angry] were obtained at frequencies&#xD;
           including 130 Hz, 60 Hz, 99 Hz, 230 Hz and off-stimulation. The face photos will&#xD;
           evaluate by the software and by the volunteers with the aim of a website:&#xD;
           http://www.supporttoscience.com&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study initially recruited 18 patients with idiopathic PD who underwent DBS surgery for movement disorders caused by PD at Mustafa Kemal University Medical Faculty Neurosurgery Department.&#xD;
Inclusion criteria:&#xD;
Idiopathic PD responsive to L-Dopa treatment,&#xD;
Between 40-75 years of age,&#xD;
Having received bilateral STN DBS surgery at least six months prior to the investigation to ensure stable stimulation parameters,&#xD;
Mentally normal patients that could understand and respond to a directives.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of Deep brain stimulation on facial expressions will be analyzed by volunteers via a web site then the results will evaluate by statistical analyses.</measure>
    <time_frame>3 months</time_frame>
    <description>The evaluation of patients photos (in different frequencies and when stimulation off status) will be analyzed by volunteers via a website, then the results will be compare and evaluate by statistical analysis. The results will give us an opinion about these:&#xD;
The effect of Deep Brain Stimulation on Parkinsonians patients facial expression and which frequency setting is better for facial expression.</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Parkinson</condition>
  <arm_group>
    <arm_group_label>DBS off</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DBS on 60 Hz.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DBS on 99 Hz.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DBS on 130 Hz.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DBS on 230 Hz.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>Deep Brain Stimulation is an established surgical method for Parkinson's Disease.</description>
    <arm_group_label>DBS off</arm_group_label>
    <arm_group_label>DBS on 130 Hz.</arm_group_label>
    <arm_group_label>DBS on 230 Hz.</arm_group_label>
    <arm_group_label>DBS on 60 Hz.</arm_group_label>
    <arm_group_label>DBS on 99 Hz.</arm_group_label>
    <other_name>Vercise</other_name>
    <other_name>Activa PC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Idiopathic PD responsive to L-Dopa treatment,&#xD;
&#xD;
          -  Between 40-75 years of age,&#xD;
&#xD;
          -  Having received bilateral STN DBS surgery at least one month prior to the&#xD;
             investigation to ensure stable stimulation parameters,&#xD;
&#xD;
          -  Mentally normal patients that could understand and respond to a questionnaire.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Above 75 years of age,&#xD;
&#xD;
          -  Severe dementia,&#xD;
&#xD;
          -  History of an additional neurologic disease,&#xD;
&#xD;
          -  The presence of a disease, such as the facial paralysis, that could affect facial&#xD;
             expressions,&#xD;
&#xD;
          -  Having a wound on the face.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Atilla YILMAZ</last_name>
    <phone>+905322253991</phone>
    <email>atillayilmaz@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Atilla YILMAZ</name>
      <address>
        <city>Hatay</city>
        <zip>31070</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Atilla YILMAZ</last_name>
      <phone>+905322253991</phone>
      <email>atillayilmaz@hotmail.com</email>
    </contact>
    <contact_backup>
      <email>atillayilmaz@mku.edu.tr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>May 28, 2018</study_first_submitted>
  <study_first_submitted_qc>June 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2018</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mustafa Kemal University</investigator_affiliation>
    <investigator_full_name>Atilla YILMAZ</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Parkinson's Disease</keyword>
  <keyword>Deep Brain Stimulation</keyword>
  <keyword>Subthalamic Nucleus</keyword>
  <keyword>DBS</keyword>
  <keyword>STN</keyword>
  <keyword>Face</keyword>
  <keyword>Facial expressions</keyword>
  <keyword>Parkinson</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The results will be shared</ipd_description>
    <ipd_url>http://www.supporttoscience.com</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

